Anna Vildhede
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 18
- Drug Transport and Resistance Mechanisms 17
-
- Pharmacogenetics and Drug Metabolism 8
- Drug-Induced Hepatotoxicity and Protection 4
- Co-authors
- Per Artursson (9 shared papers)Jacek R. Wiśniewski (6 shared papers)Maria Karlgren (6 shared papers)Agneta Norén (5 shared papers)Emi Kimoto (6 shared papers)Yurong Lai (3 shared papers)U Haglund (2 shared papers)Ulf Norinder (1 shared paper)
- Journals
- Drug Metabolism and Disposition (5 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)CPT Pharmacometrics & Systems Pharmacology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Drug Metabolism and Pharmacokinetics (1 paper)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Anna Vildhede
22 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 87
- Pharmacology 341
- Oncology 584
- Hepatology 101
- Pediatrics, Perinatology and Child Health 239
- Biochemistry 52
Countries citing papers authored by Anna Vildhede
This map shows the geographic impact of Anna Vildhede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Vildhede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Vildhede more than expected).
Fields of papers citing papers by Anna Vildhede
This network shows the impact of papers produced by Anna Vildhede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Vildhede. The network helps show where Anna Vildhede may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Vildhede, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 297 | |
| 2 | 2016 | 146 | |
| 3 | 2014 | 100 | |
| 4 | 2015 | 97 | |
| 5 | 2019 | 58 | |
| 6 | 2020 | 55 | |
| 7 | 2016 | 45 | |
| 8 | 2017 | 40 | |
| 9 | 2018 | 33 | |
| 10 | 2018 | 26 | |
| 11 | 2018 | 22 | |
| 12 | 2017 | 22 | |
| 13 | 2021 | 20 | |
| 14 | 2022 | 15 | |
| 15 | 2017 | 11 | |
| 16 | 2023 | 9 | |
| 17 | 2018 | 7 | |
| 18 | 2024 | 5 | |
| 19 | 2021 | 3 | |
| 20 | 2018 | 2 |
About Anna Vildhede
Anna Vildhede is a scholar working on Oncology, Pharmacology, Epidemiology, Infectious Diseases and Pediatrics, Perinatology and Child Health, having authored 23 papers that have together received 1.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (17 papers), Pharmacogenetics and Drug Metabolism (8 papers), Liver Disease Diagnosis and Treatment (8 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), HIV/AIDS drug development and treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Metabolism and Genetic Disorders (3 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Pharmacology (341 citations), Oncology (584 citations), Hepatology (101 citations), Pediatrics, Perinatology and Child Health (239 citations) and Biochemistry (52 citations). Anna Vildhede has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Per Artursson, Jacek R. Wiśniewski, Maria Karlgren, Agneta Norén, Emi Kimoto, Yurong Lai, U Haglund, Ulf Norinder, Manthena V. S. Varma and A. David Rodrigues. Their work appears in journals such as Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, CPT Pharmacometrics & Systems Pharmacology, Clinical Pharmacology & Therapeutics and Drug Metabolism and Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.